MTOR and breast carcinoma: mTOR and ribosomal protein S6 Kinase Beta-1 (p-S6K1) were found to be elevated in breast cancer cells (32, 33). CD44high/CD24low Michigan Cancer Foundation-7 (MCF-7) cells, a radioresistant breast cancer cell line, expresses higher levels of p-S6K1 than radiosensitive cells, suggesting a possible correlation between p-S6K1 and radiation resistance.